Association of circulating uric acid and angiotensin-(1-7) in relation to higher blood pressure in adolescents and the influence of preterm birth

Andrew M South, Hossam A Shaltout, Patricia A Nixon, Debra I Diz, Elizabeth T Jensen, T Michael O'Shea, Mark C Chappell, Lisa K Washburn, Andrew M South, Hossam A Shaltout, Patricia A Nixon, Debra I Diz, Elizabeth T Jensen, T Michael O'Shea, Mark C Chappell, Lisa K Washburn

Abstract

Elevated serum uric acid increases the risk of hypertension, and individuals born preterm have higher blood pressure (BP) and uric acid, but the mechanisms remain unclear. Preclinical studies demonstrate uric acid increases BP via increased renin-angiotensin system (RAS) expression, especially angiotensin (Ang) II, but the association of uric acid with Ang-(1-7) is unknown. Ang-(1-7), an alternative RAS product, counteracts Ang II by stimulating sodium excretion, vasodilation, and nitric oxide, thus contributing to lower BP. Plasma Ang-(1-7) is lower in preterm-born adolescents. We hypothesized uric acid is associated with a higher ratio of Ang II to Ang-(1-7) in plasma, especially in preterm-born adolescents. We measured BP, serum uric acid, and plasma RAS components in a cross-sectional analysis of 163 14-year olds (120 preterm, 43 term). We estimated the associations between uric acid and the RAS using generalized linear models adjusted for sex, obesity, sodium intake, and fat intake, stratified by birth status. Uric acid was positively associated with Ang II/Ang-(1-7) (adjusted β (aβ): 0.88 mg/dl, 95% CI 0.17-1.58), plasma renin activity (aβ: 0.32 mg/dl, 95% CI 0.07-0.56), and aldosterone (aβ: 1.26 mg/dl, 95% CI 0.18-2.35), and inversely with Ang-(1-7) (aβ: -1.11 mg/dl, 95% CI -2.39 to 0.18); preterm birth did not modify these associations. Higher Ang II/Ang-(1-7) was associated with higher uric acid in adolescents. As preterm birth is associated with higher BP and uric acid, but lower Ang-(1-7), the imbalance between uric acid and Ang-(1-7) may be an important mechanism for the development of hypertension.

Conflict of interest statement

Conflicts of interest: None.

Figures

Fig. 1
Fig. 1
Study flow diagram
Fig. 2
Fig. 2
A-BCorrelation between serum uric acid and plasma Ang II/Ang-(1–7) in preterm-born and term-born adolescents Loess fitted curves in black with confidence limits for mean predicted values in grey shading; individual data points and unadjusted generalized linear model regression coefficients with corresponding p values are provided. A: Preterm-birth cohort, unadjusted β (95% CI) 0.78 (−0.01, 1.56), p = 0.05. B: Term-birth cohort, unadjusted β (95% CI) 0.19 (−0.52, 0.9), p = 0.6. Ang, angiotensin.
Fig. 3
Fig. 3
Conceptual diagram of the uric acid – Ang-(1–7) – BP association Programming events such as preterm birth may increase uric acid expression which then may suppress Ang-(1–7) expression but correspondingly increase Ang II expression. This in turn could lead to renal sodium retention and increased BP. In addition, Ang II-mediated increased oxidative stress, in part via upregulation of NF-κB and ERK and downregulation of PI3K leading to reduced eNOS but increased ROS, could increase inflammation in the kidneys, vasculature, and heart ultimately promoting development of hypertension and cardiovascular disease. Ang, angiotensin; BP, blood pressure; eNOS, endothelial nitric oxide synthase; ERK, extracellular regulated kinase; NF-κB, nuclear factor kappa enhancer of B cells; PI3K, phosphoinositide 3-kinase; RAS, renin-angiotensin system; ROS, reactive oxygen species.

References

    1. Benjamin EJ, Virani SS, Callaway CW, Chang AR, Cheng S, Chiuve SE, et al. Heart Disease and Stroke Statistics—2018 Update: a Report from the American Heart Association. Circulation. 2018; 137(12): e67–e492.
    1. Muntner P, Carey RM, Gidding S, Jones DW, Taler SJ, Wright JT, et al. Potential US population impact of the 2017 ACC/AHA High Blood Pressure Guideline. Circulation. 2018; 137(2): 109–18.
    1. Evensen KAI, Steinshamn S, Tjønna AE, Stølen T, Høydal MA, Wisløff U, et al. Effects of preterm birth and fetal growth retardation on cardiovascular risk factors in young adulthood. Early Hum Dev. 2009; 85(4): 239–45.
    1. Sundström J, Sullivan L, D’Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005; 45(1): 28–33.
    1. Washburn LK, Nixon PA, Russell GB, Snively BM, O’Shea TM. Preterm birth is associated with higher uric acid levels in adolescents. J Pediatr. 2015; 167(1): 76–80.
    1. Yu M-A, Sánchez-Lozada LG, Johnson RJ, Kang D-H. Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction. J Hypertens. 2010; 28(6): 1234–42.
    1. Shaltout HA, Figueroa JP, Rose JC, Diz DI, Chappell MC. Alterations in circulatory and renal angiotensin-converting enzyme and angiotensin-converting enzyme 2 in fetal programmed hypertension. Hypertension. 2009; 53(2): 404–8.
    1. Sampaio WO, Henrique de Castro C, Santos RAS, Schiffrin EL, Touyz RM. Angiotensin-(1–7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension. 2007; 50(6): 1093–8.
    1. Washburn LK, Brosnihan KB, Chappell MC, Diz DI, Gwathmey TM, Nixon PA, et al. The renin–angiotensin–aldosterone system in adolescent offspring born prematurely to mothers with preeclampsia. J Renin Angiotensin Aldosterone Syst. 2015; 16(3): 529–38.
    1. South AM, Nixon PA, Chappell MC, Diz DI, Russell GB, Jensen ET, et al. Association between preterm birth and the renin-angiotensin system in adolescence: influence of sex and obesity. J Hypertens. 2018; 36(10): 2092–101.
    1. Mulè G, Castiglia A, Morreale M, Geraci G, Cusumano C, Guarino L, et al. Serum uric acid is not independently associated with plasma renin activity and plasma aldosterone in hypertensive adults. Nutr Metab Cardiovasc Dis. 2017; 27(4): 350–9.
    1. Russell BK. Babies who are small for gestational age. Pediatr Rev. 1995; 16(9): 354.
    1. Barlow SE. Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report. Pediatrics. 2007; 120 Suppl 4: S164–92.
    1. Taylor SJ, Whincup PH, Hindmarsh PC, Lampe F, Odoki K, Cook DG. Performance of a new pubertal self-assessment questionnaire: a preliminary study. Paediatr Perinat Epidemiol. 2001; 15(1): 88–94.
    1. 2015–2020 Dietary Guidelines for Americans: U.S. Department of Health and Human Services and U.S. Department of Agriculture; 2015. [cited 2018 August 24, 2018]. 8th Available from: .
    1. Update on the 1987 Task Force Report on High Blood Pressure in Children and Adolescents: a Working Group Report from the National High Blood Pressure Education Program. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Pediatrics. 1996; 98 (4 Pt 1): 649–58.
    1. Rosner B, Cook N, Portman R, Daniels S, Falkner B. Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol. 2008; 167(6): 653–66.
    1. South AM, Nixon PA, Chappell MC, Diz DI, Russell GB, Jensen ET, et al. Renal function and blood pressure are altered in adolescents born preterm. Pediatr Nephrol. 2019; 34(1): 137–44.
    1. Flynn JT, Kaelber DC, Baker-Smith CM, Blowey D, Carroll AE, Daniels SR, et al. Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents. Pediatrics. 2017; 140(3): e20171904.
    1. Chappell MC. Biochemical evaluation of the renin-angiotensin system: the good, bad, and absolute? Am J Physiol Heart Circ Physiol. 2016; 310(2): H137–H52.
    1. Croghan C, Egeghy PP. Methods of dealing with values below the limit of detection using SAS. Southeastern SAS User Group; 2003 September 22–24, 2003; St. Petersburg, FL.
    1. Shrier I, Platt RW. Reducing bias through directed acyclic graphs. BMC Med Res Methodol. 2008; 8: 70.
    1. Cappuccio FP, Strazzullo P, Farinaro E, Trevisan M. Uric acid metabolism and tubular sodium handling: results from a population-based study. J Am Med Assoc. 1993; 270(3): 354–9.
    1. Viazzi F, Antolini L, Giussani M, Brambilla P, Galbiati S, Mastriani S, et al. Serum uric acid and blood pressure in children at cardiovascular risk. Pediatrics. 2013; 132(1): e93–e9.
    1. Perez-Ruiz F, Calabozo M, Erauskin GG, Ruibal A, Herrero-Beites AM. Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output. Arthritis Care Res (Hoboken). 2002; 47(6): 610–3.
    1. Corry DB, Eslami P, Yamamoto K, Nyby MD, Makino H, Tuck ML. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin–angiotensin system. J Hypertens. 2008; 26(2): 269–75.
    1. Chappell M, Marshall A, Al Zayadneh EM, Shaltout H, Diz D. Update on the angiotensin converting enzyme 2-angiotensin (1–7)-Mas receptor axis: fetal programing, sex differences, and intracellular pathways. Front Endocrinol (Lausanne). 2014; 4: 201.
    1. Fabbrini E, Serafini M, Colic Baric I, Hazen SL, Klein S. Effect of plasma uric acid on antioxidant capacity, oxidative stress, and insulin sensitivity in obese subjects. Diabetes. 2014; 63(3): 976–81.
    1. South AM, Shaltout Hossam A, Washburn Lisa K, Hendricks Alexa S, Diz Debra I, Chappell Mark C. Fetal programming and the angiotensin-(1–7) axis: a review of the experimental and clinical data. Clin Sci. 2019; 133(1): 55–74.
    1. Washburn LK, Nixon PA, Shaltout HA, South AM, O’Shea TM. Impaired stress-induced pressure natriuresis in young adults born with very low birth weight. Pediatr Acad Soc. 2017; E-PAS2017 (abstract 2300.1).
    1. Wang Y, Hu J-W, Lv Y-B, Chu C, Wang K-K, Zheng W-L, et al. The role of uric acid in hypertension of adolescents, prehypertension and salt sensitivity of blood pressure. Med Sci Monit. 2017; 23: 790–5.
    1. Ruys CA, Rotteveel J, van de Lagemaat M, Lafeber HN, Finken MJJ. Salt sensitivity of blood pressure at age 8 years in children born preterm. J Hum Hypertens. 2018; 32(5): 367–76.
    1. Wang Y, Chu C, Wang K-K, Hu J-W, Yan Y, Lv Y-B, et al. Effect of salt intake on plasma and urinary uric acid levels in chinese adults: an interventional trial. Sci Rep. 2018; 8(1): 1434.
    1. Grayson PC, Kim SY, LaValley M, Choi HK. Hyperuricemia and incident hypertension: a systematic review and meta-analysis. Arthritis Care Res (Hoboken). 2010; 63(1): 102–10.
    1. McMullan CJ, Borgi L, Fisher N, Curhan G, Forman J. Effect of uric acid lowering on renin-angiotensin-system activation and ambulatory BP: a randomized controlled trial. Clin J Am Soc Nephrol. 2017; 12(5): 807–16.
    1. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial. J Am Med Assoc. 2008; 300(8): 924–32.

Source: PubMed

3
Prenumerera